Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 109
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00002132 | Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. | ||
| NCT02955810 | Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) | ||
| NCT03522259 | Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery | ||
| NCT05619536 | Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects | ||
| NCT03696160 | The Late Presenter Treatment Optimisation Study | ||
| NCT03063203 | Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia | ||
| NCT03655223 | Early Check: Expanded Screening in Newborns | ||
| NCT03450057 | Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment | ||
| NCT01717053 | Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | ||
| NCT03939182 | Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma | ||
| NCT03823924 | Changes in Body Composition Under Ustekinumab in PsA | ||
| NCT02373930 | Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects | ||
| NCT04399551 | A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries | ||
| NCT02207062 | Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma | ||
| NCT03290950 | A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT06396533 | Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) | ||
| NCT05523089 | The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults | ||
| NCT03283917 | Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT04089345 | Stelara fOr ChRonic AntibioTic rEfractory pouchitiS | ||
| NCT02478632 | Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen | ||
| NCT02929745 | Single Cell Genomics of Psoriatic Skin | ||
| NCT05109559 | Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine | ||
| NCT01236391 | Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL) | ||
| NCT07110844 | Teclistamab-Daratumumab in AL Amyloidosis | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT05304858 | Tumor Microenvironment Analysis of Prostate Cancer Metastasis | ||
| NCT06232551 | Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism | ||
| NCT03093272 | A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer | ||
| NCT02438631 | Placental Passage and Disposition of Drugs: A Physiology-based Approach | ||
| NCT06083922 | A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) | ||
| NCT03475628 | Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma | ||
| NCT03899155 | Pan Tumor Rollover Study | ||
| NCT04116606 | Antidepressant Trial With P2X7 Antagonist JNJ-54175446 | ||
| NCT02429791 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1) | ||
| NCT02422797 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2) | ||
| NCT05546242 | Improving HIV-1 Control in Africa with Long Acting Antiretrovirals | ||
| NCT03586570 | A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects | ||
| NCT01905059 | Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa | ||
| NCT02841033 | Daratumumab for the Treatment of Patients With AL Amyloidosis | ||
| NCT01848028 | PsoBest - The German Psoriasis Registry | ||
| NCT06856902 | BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe | ||
| NCT02838693 | Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes) | ||
| NCT06066346 | A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy | ||
| NCT02867020 | Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels | ||
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | ||
| NCT01701063 | An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus | ||
| NCT02951052 | Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults | ||
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | ||
| NCT05486481 | Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) |
